OTC Watch

All stocks / ADIA

Adia Med, Inc. ADIA

Adia Med (ADIA): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated float OTCQBFlorida, USA
Live quote on OTC Markets

Market listing

Full name
ADIA MED INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 13
Source: Stockwatch, 2026-11-17

News headlines

ADIA Med Nearly Doubles Nine-Month Revenue to Surpass $1 Million
2026-11-17 08:01 · News Release
Adia Med CEO Larry Powalisz Issues Open Letter on Leadership Journey, Research Mission, and Progress Since 2024
2026-11-09 08:01 · News Release
Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues
2026-10-26 08:02 · News Release
Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash
2026-10-20 08:01 · News Release
Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position
2026-10-13 09:01 · News Release
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
2026-10-06 09:21 · News Release
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
2026-09-29 08:01 · News Release
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products
2026-09-22 08:01 · News Release
Adia Med Submits Fifth 2026 Clinical Study to IRB: Osteoarthritis Protocol for One-Time Systemic Treatment
2026-09-15 08:01 · News Release
Nasdaq Shareholder Requirements Just Verified By Adia Med
2026-09-08 08:01 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$700,508
Net loss
($395,464)
What it means

It spends more than it earns

Under strain

Customers paid it $700,508 in the year. It lost $395,464. For every $1 that came in, about $1.56 went out.

The report says
Cash and cash equivalents
$79,392
Net cash used in operating activities
($179,228)
What it means

The cash could run out soon

Under strain

It had $79,392 in the bank and used about $14,936 a month. At that pace the money lasts about 5 months unless it borrows or sells more shares.

The report says
Total assets
$594,826
Total liabilities
$852,500
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $594,826. Its debts and unpaid bills add up to $852,500. That is about $1.43 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-16

Estimated float about 94,404,696 shares as of 2026-11-16: 94,404,696 outstanding minus 0 held by 0 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2026-03-31
94.4M
2026-05-15
94.4M
2026-08-13
94.4M
2026-11-16
94.4M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 10-QFORM 10-Q FOR SEP 2026
2026-10-19 8-KCURRENT REPORT
2026-10-13 8-KCURRENT REPORT
2026-10-06 8-KCURRENT REPORT
2026-10-05 8-KCURRENT REPORT
2026-08-24 8-KCURRENT REPORT
2026-08-17 8-KCURRENT REPORT
2026-08-13 10-QFORM 10-Q FOR JUN 2026
2026-05-15 10-QFORM 10-Q FOR MAR 2026
2026-03-31 10-KFORM 10-K FOR DEC 2025
2025-12-05 10-12GFORM 10-12(G)

Common questions about ADIA

Does ADIA file reports with the SEC?

Yes. Adia Med files with the SEC under company number 0001160420. The most recent filing we hold is a 10-Q dated 2026-11-16.

Source record

How many ADIA shares are outstanding?

94,404,696 shares as of 2026-11-16, as reported to the SEC.

Source record

Has ADIA filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is Adia Med making money?

Customers paid it $700,508 in the year. It lost $395,464. For every $1 that came in, about $1.56 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record